(Q38452107)

3 September 2017

1 reference

title

Pharmacometabonomics in humans: a new tool for personalized medicine (English)

1 reference

3 September 2017

main subject

personalized medicine

1 reference

Jeremy R Everett

1

1 reference

3 September 2017

publication date

1 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

16

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

737-754

1 reference

A challenging drug development process in the era of personalized medicine

3 September 2017

cites work

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis

21 January 2018

1 reference

Clinical and economic burden of adverse drug reactions

21 January 2018

1 reference

The emerging era of pharmacogenomics: current successes, future potential, and challenges

21 January 2018

1 reference

Personalized pharmacogenomics: predicting efficacy and adverse drug reactions

21 January 2018

1 reference

Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.

21 January 2018

1 reference

The pharmacogenetics of type 2 diabetes: a systematic review

21 January 2018

1 reference

Pharmacogenomic testing and personalized treatment of depression

21 January 2018

1 reference

Pharmacogenomics: Current State-of-the-Art

21 January 2018

1 reference

Metabolomics – the link between genotypes and phenotypes

21 January 2018

1 reference

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

21 January 2018

1 reference

Enteric microbiome metabolites correlate with response to simvastatin treatment

21 January 2018

1 reference

Proposed minimum reporting standards for chemical analysis

21 January 2018

1 reference

Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics

21 January 2018

1 reference

Metabolite identification: are you sure? And how do your peers gauge your confidence?

21 January 2018

1 reference

A new paradigm for known metabolite identification in metabonomics/metabolomics: metabolite identification efficiency

21 January 2018

1 reference

HMDB 3.0--The Human Metabolome Database in 2013

21 January 2018

1 reference

Scaling and normalization effects in NMR spectroscopic metabonomic data sets

21 January 2018

1 reference

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics

21 January 2018

1 reference

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring

21 January 2018

1 reference

Pharmacometabonomics and personalized medicine

21 January 2018

1 reference

Pharmacometabonomics as an effector for personalized medicine.

21 January 2018

1 reference

Pharma-metabolomics in neonatology: is it a dream or a fact?

21 January 2018

1 reference

Pharmaceutical research and metabolomics in the newborn

21 January 2018

1 reference

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

21 January 2018

1 reference

Prediction of variability in CYP3A4 induction using a combined 1H NMR metabonomics and targeted UPLC-MS approach.

21 January 2018

1 reference

Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance.

21 January 2018

1 reference

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

21 January 2018

1 reference

Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment

21 January 2018

1 reference

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics

21 January 2018

1 reference

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

21 January 2018

1 reference

Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo

21 January 2018

1 reference

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway

21 January 2018

1 reference

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

21 January 2018

1 reference

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy

21 January 2018

1 reference

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability

21 January 2018

1 reference

Serum molecular signatures of weight change during early breast cancer chemotherapy.

21 January 2018

1 reference

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine.

21 January 2018

1 reference

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

Pharmacometabolomics reveals racial differences in response to atenolol treatment

21 January 2018

1 reference

Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics

21 January 2018

1 reference

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.

21 January 2018

1 reference

Human metabolic individuality in biomedical and pharmaceutical research

21 January 2018

1 reference

A genome-wide association study of metabolic traits in human urine

21 January 2018

1 reference

Genome-wide association study identifies multiple loci influencing human serum metabolite levels

21 January 2018

1 reference

An atlas of genetic influences on human blood metabolites

21 January 2018

1 reference

Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links

21 January 2018

1 reference

Characterization of biopharmaceuticals by NMR spectroscopy

21 January 2018

1 reference

NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations

21 January 2018

1 reference

'Personalized medicine': what’s in a name?

21 January 2018

1 reference

NMR Spectroscopy of Biofluids

21 January 2018

1 reference

Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.15.20

1 reference

3 September 2017

1 reference